Acquisition by Virnich Daniel of 198517 shares of Oncology Institute subject to Rule 16b-3
| TOI Stock | USD 1.00 0.01 0.99% |
Under 52% of Oncology Institute's traders are presently thinking to get in. The analysis of overall sentiment of trading Oncology Institute stock suggests that some investors are interested at this time. Oncology Institute's investing sentiment shows overall attitude of investors towards Oncology Institute.
Oncology |
Filed transaction by Oncology Institute Officer Chief Executive Officer. Grant, award or other acquisition pursuant to Rule 16b-3
Read at macroaxis.com
Oncology Institute Fundamental Analysis
We analyze Oncology Institute's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Oncology Institute using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Oncology Institute based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Total Asset
Total Asset Comparative Analysis
Oncology Institute is currently under evaluation in total asset category among its peers. Total Asset is everything that a business owns. It is the sum of current and long-term assets owned by a firm at a given time. These assets are listed on a balance sheet and typically valued based on their purchasing prices, not the current market value.
Oncology Institute Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Oncology Institute stock to make a market-neutral strategy. Peer analysis of Oncology Institute could also be used in its relative valuation, which is a method of valuing Oncology Institute by comparing valuation metrics with similar companies.
Peers
Oncology Institute Related Equities
| EHC | Encompass Health | 0.87 | ||||
| LFST | Lifestance Health | 0.50 | ||||
| UHS | Universal Health | 0.39 | ||||
| MFCSF | Medical Facilities | 0.53 | ||||
| AMS | American Shared | 0.64 | ||||
| SEM | Select Medical | 0.81 | ||||
| ADUS | Addus HomeCare | 0.93 | ||||
| SGRY | Surgery Partners | 1.01 | ||||
| FSNUY | Fresenius | 1.44 | ||||
| ENSG | Ensign | 2.20 | ||||
| BKD | Brookdale Senior | 2.53 | ||||
| JYNT | Joint Corp | 2.56 | ||||
| MD | Mednax | 2.98 | ||||
| SNDA | Sonida Senior | 3.27 | ||||
| PNTG | Pennant | 3.68 | ||||
| RMYHY | Ramsay Health | 4.55 | ||||
| CCM | Concord Medical | 5.11 | ||||
| AGL | Agilon Health | 6.96 |
Complementary Tools for Oncology Stock analysis
When running Oncology Institute's price analysis, check to measure Oncology Institute's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Oncology Institute is operating at the current time. Most of Oncology Institute's value examination focuses on studying past and present price action to predict the probability of Oncology Institute's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Oncology Institute's price. Additionally, you may evaluate how the addition of Oncology Institute to your portfolios can decrease your overall portfolio volatility.
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. |